Michael Manns

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Medicine, Internal Medicine, Pharmacology +8

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 466 citations

Medicine, Internal Medicine, Pharmacotherapy +12

All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study

Michael Manns, S. Pol, Ira M. Jacobson et al. · The Lancet · 2014 · 343 citations

Pharmacy, Infectious Diseases, Hepatitis Pharmacotherapy +13

Experimental Autoimmune Hepatitis: Disease Induction, Time Course and T–Cell Reactivity

Ansgar W. Lohse, Michael Manns, Hans‐Peter Dienes et al. · Hepatology · 1990 · 130 citations

Medicine, Immunology, Pathology +17

Autoantibodies to Human Asialoglycoprotein Receptor in Autoimmune–Type Chronic Hepatitis

Ulrich Treichel, Thomas Poralla, Georg Hess et al. · Hepatology · 1990 · 113 citations · Full text

Life Sciences, Immunology, Pathology +14